Adamant Biomedical Investments »

Infinity Pharmaceuticals shares owned by Adamant Biomedical Investments

Quarter-by-quarter ownership of Infinity Pharmaceuticals (INFIQ) shares owned by Adamant Biomedical Investments from 13F filings

Historical chart of Adamant Biomedical Investments investment in Infinity Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Infinity Pharmaceuticals held by Adamant Biomedical Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Infinity Pharmaceuticals by Adamant Biomedical Investments

Quarter filed Position value Share count Share price at filing
2014-12-31 $287k 17k 16.88
2014-09-30 $228k 17k 13.41

More positions owned by Adamant Biomedical Investments

Celgene Corporation
Biogen Idec (BIIB)
Gilead Sciences (GILD)
Amgen (AMGN)
Actavis
UnitedHealth (UNH)
Mylan
Catamaran
Alexion Pharmaceuticals
Medtronic
Vertex Pharmaceuticals Incorporated (VRTX)
Regeneron Pharmaceuticals (REGN)
McKesson Corporation (MCK)
Auris Med Hldg
Mallinckrodt Pub

View all positions for Adamant Biomedical Investments

Top funds holding Infinity Pharmaceuticals

Highlander Capital Management
Able Wealth Management
Livelsberger Financial Advisory

View all funds holding Infinity Pharmaceuticals